ARCHIVES

SWOG Opens Phase II Trial Of CuraGen’s HDAC Inhibitor For B-Cell Lymphoma

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Clinton Appoints Breast Cancer coalition’s Fran Visco to President’s Cancer Panel

May 21, 1993

Scientific Process

September 25, 1998

Senior Biomedical Service Proposed To Increase Pay

April 1, 1988

In Brief: DeVita On Laetrile Hit List; Hammer Removal As Panel Head Sought By Love Canal Activist

November 6, 1981

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

NCI Programs: Unequal Outcomes For Minorities The Result of Unequal Treatment NCI Suggests Awareness Campaign

December 17, 1999